The content in this page is take from the Usher Syndrome Coalition website and it is of their property. We…
Original article on AP News QR-421a showed early and encouraging evidence of activity, with 25% of patients showing a benefit…
ProQR is developing a novel investigational drug called QR-421a to treat RP in patients that have USH2 due to a…